Literature DB >> 7451492

4-Aminobutyrate aminotransferase. The presence of nonequivalent binding sites.

J E Churchich, U Moses.   

Abstract

A homogeneous 4-aminobutyrate aminotransferase isolated from pig brain exhibits a kcat = 9.6 s-1 and contains only 1 mol of pyridoxal-5-P/mol of dimer. The equilibrium dissociation constant for pyridoxal-5-P tightly bound to the enzyme is 1 nM. Spectrophotometric titrations reveal that the enzyme binds a second molecule of pyridoxal-5-P with a KD = 3 microM. The reaction of enzyme containing 1 pyridoxal-5-P/dimer with the inhibitors NaBH4 and DL-gabaculine was studied by observing changes in the absorption spectrum of the bound coenzyme and by monitoring loss of catalytic activity. The native enzyme is inactivated by both inhibitors. Incubation of the resultant P-pyridoxyl aminotransferase and m-anthraniyl-PMP-aminotransferase with excess pyridoxal-5-P at 25 degrees C restores full catalytic activity. It is postulated that the dimeric enzyme contains two classes of catalytic binding sites, and that the binding site characterized by a weak affinity for pyridoxal-5-P (KD = 3 microM) becomes functional after specific chemical modification of the molecule of cofactor tightly bound to the protein (KD - 1 nM).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7451492

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  The 2011 E. B. Hershberg award for important discoveries in medicinally active substances: (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a GABA aminotransferase inactivator and new treatment for drug addiction and infantile spasms.

Authors:  Richard B Silverman
Journal:  J Med Chem       Date:  2012-01-10       Impact factor: 7.446

2.  Cofactor interactions and the regulation of glutamate decarboxylase activity.

Authors:  D L Martin; S B Martin; S J Wu; N Espina
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

Review 3.  4-Aminobutyrate aminotransferase (GABA-transaminase) deficiency.

Authors:  L K Medina-Kauwe; A J Tobin; L De Meirleir; J Jaeken; C Jakobs; W L Nyhan; K M Gibson
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

4.  (+/-)-(1S,2R,5S)-5-Amino-2-fluorocyclohex-3-enecarboxylic acid. A potent GABA aminotransferase inactivator that irreversibly inhibits via an elimination-aromatization pathway.

Authors:  Zhiyong Wang; Hai Yuan; Dejan Nikolic; Richard B Van Breemen; Richard B Silverman
Journal:  Biochemistry       Date:  2006-12-05       Impact factor: 3.162

5.  Probing the steric requirements of the γ-aminobutyric acid aminotransferase active site with fluorinated analogues of vigabatrin.

Authors:  Jose I Juncosa; Andrew P Groves; Guoyao Xia; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2012-12-20       Impact factor: 3.641

6.  Characteristics of alanine: glyoxylate aminotransferase from Saccharomyces cerevisiae, a regulatory enzyme in the glyoxylate pathway of glycine and serine biosynthesis from tricarboxylic acid-cycle intermediates.

Authors:  Y Takada; T Noguchi
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.